0001209191-23-044535.txt : 20230803 0001209191-23-044535.hdr.sgml : 20230803 20230803180335 ACCESSION NUMBER: 0001209191-23-044535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230801 FILED AS OF DATE: 20230803 DATE AS OF CHANGE: 20230803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas Dolca CENTRAL INDEX KEY: 0001768239 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38582 FILM NUMBER: 231141514 MAIL ADDRESS: STREET 1: C/O PRINCIPIA BIOPHARMA INC. STREET 2: 220 E. GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allakos Inc. CENTRAL INDEX KEY: 0001564824 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454798831 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: SUITE 500 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-597-5002 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: SUITE 500 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-01 0 0001564824 Allakos Inc. ALLK 0001768239 Thomas Dolca C/O ALLAKOS INC. 825 INDUSTRIAL ROAD, SUITE 500 SAN CARLOS CA 94070 1 0 0 0 0 Stock Option (Right to buy) 5.55 2023-08-01 4 A 0 154786 0.00 A 2033-08-01 Common Stock 154786 154786 D The option vests as to one thirty-sixth (1/36) of the shares monthly over a three year period, subject to the Reporting Person continuing as a service provider through each such date. /s/ H. Baird Radford, III, by power of attorney 2023-08-03